Table 1.
Patient demographics
| Variables | No. of patients (n = 172) | (%) |
|---|---|---|
| Age, years (median, range) | 54 (30–76) | |
| BMI, kg/m2 (mean ± SD) | 22.9 ± 3.8 | |
| WHO BMI classification | ||
| Underweight (BMI < 18.5 kg/m2) | 18 | (10) |
| Normal range (18.5 ≤ BMI < 25 kg/m2) | 111 | (65) |
| Overweight (25 ≤ BMI < 30 kg/m2) | 35 | (20) |
| Obese (BMI ≥ 30 kg/m2) | 8 | (5) |
| Subcutaneous fat area, cm2 (mean ± SD) | 138.2 ± 65.3 | |
| Visceral fat area, cm2 (median, range) | 73.0 (5–317) | |
| V/S ratio, % (median, range) | 52 (15–223) | |
| Lumber skeletal muscle index, cm2/cm3 (mean ± SD) | 57.5 ± 7.5 | |
| Liver/spleen HU ratio (median, range) | 1.3 (0.1–2.0) | |
| Menopausal status | ||
| Premenopausal | 74 | (43) |
| Postmenopausal | 98 | (57) |
| T | ||
| 1 | 0 | (0) |
| 2 | 119 | (69) |
| 3 | 24 | (14) |
| 4 | 28 | (16) |
| Histological type | ||
| Ductal | 140 | (81) |
| Other | 32 | (19) |
| Subtype | ||
| ER (+), HER2 (−) | 77 | (45) |
| ER (+), HER2 (+) | 30 | (17) |
| HER2 | 34 | (20) |
| Triple‐negative | 31 | (18) |
BMI, body mass index; SD, standard deviation; WHO, World Health Organization; V/S ratio, visceral/subcutaneous fat ratio; HU, Hounsfield unit; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2.